|
1
|
Crew KD and Neugut AI: Epidemiology of
gastric cancer. World J Gastroenterol. 12:354–362. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sano T and Aiko T: New Japanese
classifications and treatment guidelines for gastric cancer:
Revision concepts and major revised points. Gastric Cancer.
14:97–100. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Koizumi W, Narahara H, Hara T, Takagane A,
Akiya T, Takagi M, Miyashita K, Nishizaki T, Kobayashi O, Takiyama
W, et al: S-1 plus cisplatin versus S-1 alone for first-line
treatment of advanced gastric cancer (SPIRITS trial): A phase III
trial. Lancet Oncol. 9:215–221. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yoshida K, Ninomiya M, Takakura N,
Hirabayashi N, Takiyama W, Sato Y, Todo S, Terashima M, Gotoh M,
Sakamoto J and Nishiyama M: Phase II study of docetaxel and S-1
combination therapy for advanced or recurrent gastric cancer. Clin
Cancer Res. 12:3402–3407. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Koizumi W, Kim YH, Fujii M, Kim HK,
Imamura H, Lee KH, Hara T, Chung HC, Satoh T, Cho JY, et al:
Addition of docetaxel to S-1 without platinum prolongs survival of
patients with advanced gastric cancer: A randomized study (START).
J Cancer Res Clin Oncol. 140:319–328. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tanabe K, Suzuki T, Tokumoto N, Yamamoto
H, Yoshida K and Ohdan H: Combination therapy with docetaxel and
S-1 as a first-line treatment in patients with advanced or
recurrent gastric cancer: A retrospective analysis. World J Surg
Oncol. 8:402010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bang YJ, Van Cutsem E, Feyereislova A,
Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T,
et al: Trastuzumab in combination with chemotherapy versus
chemotherapy alone for treatment of HER2-positive advanced gastric
or gastro-oesophageal junction cancer (ToGA): A phase 3,
open-label, randomised controlled trial. Lancet. 376:687–697. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yoshida K, Yamaguchi K, Okumura N, Osada
S, Takahashi T, Tanaka Y, Tanabe K and Suzuki T: The roles of
surgical oncologists in the new era: Minimally invasive surgery for
early gastric cancer and adjuvant surgery for metastatic gastric
cancer. Pathobiology. 78:343–352. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Suzuki T, Tanabe K, Taomoto J, Yamamoto H,
Tokumoto N, Yoshida K and Ohdan H: Preliminary trial of adjuvant
surgery for advanced gastric cancer. Oncol Lett. 1:743–727.
2010.PubMed/NCBI
|
|
11
|
Satoh S, Okabe H, Teramukai S, Hasegawa S,
Ozaki N, Ueda S, Tsuji A, Sakabayashi S, Fukushima M and Sakai Y:
Phase II trial of combined treatment consisting of preoperative S-1
plus cisplatin followed by gastrectomy and postoperative S-1 for
stage IV gastric cancer. Gastric Cancer. 15:61–69. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Han DS, Suh YS, Kong SH, Lee HJ, Im SA,
Bang YJ, Kim WH and Yang HK: Outcomes of surgery aiming at curative
resection in good responder to induction chemotherapy for gastric
cancer with distant metastases. J Surg Oncol. 107:511–516. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Okabe H, Ueda S, Obama K, Hosogi H and
Sakai Y: Induction chemotherapy with S-1 plus cisplatin followed by
surgery for treatment of gastric cancer with peritoneal
dissemination. Ann Surg Oncol. 16:3227–3236. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Satoh S, Hasegawa S, Ozaki N, Okabe H,
Watanabe G, Nagayama S, Fukushima M, Takabayashi A and Sakai Y:
Retrospective analysis of 45 consecutive patients with advanced
gastric cancer treated with neoadjuvant chemotherapy using an
S-1/CDDP combination. Gastric Cancer. 9:129–135. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Martin LW and Warren RS: Current
management of colorectal liver metastases. Surg Oncol Clin N Am.
9:853–878. 2000.PubMed/NCBI
|
|
16
|
Penna C and Nordlinger B: Colorectal
metastasis (liver and lung). Surg Clin North Am. 82:1075–1090,
x-xi. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Abdalla EK, Vauthey JN, Ellis LM, Ellis V,
Pollock R, Broglio KR, Hess K and Curley SA: Recurrence and
outcomes following hepatic resection, radiofrequency ablation, and
combined resection/ablation for colorectal liver metastases. Ann
Surg. 239:818–827. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Y, Yu YY, Li W, Feng Y, Hou J, Ji Y,
Sun YH, Shen KT, Shen ZB, Qin XY and Liu TS: A phase II trial of
Xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed
by surgery for advanced gastric cancer patients with para-aortic
lymph node metastasis. Cancer Chemother Pharmacol. 73:1155–1161.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kodera Y, Ito S, Mochizuki Y, Ohashi N,
Tanaka C, Kobayashi D, Kojima H, Matsui T, Kondo K and Fujiwara M:
Long-term follow up of patients who were positive for peritoneal
lavage cytology: Final report from the CCOG0301 study. Gastric
Cancer. 15:335–337. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fukuchi M, Ishiguro T, Ogata K, Suzuki O,
Kumagai Y, Ishibashi K, Ishida H, Kuwano H and Mochiki E:
Prognostic role of conversion surgery for unresectable gastric
cancer. Ann Surg Oncol. 22:3618–3624. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Benoist S, Brouquet A, Penna C, Julié C,
El Hajjam M, Chagnon S, Mitry E, Rougier P and Nordlinger B:
Complete response of colorectal liver metastases after
chemotherapy: Does it mean cure? J Clin Oncol. 24:3939–3945. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ako E, Ohira M, Yamashita Y, Kubo N,
Muguruma K, Yashiro M, Sawada T, Nakata B, Kato Y and Hirakawa K:
Efficacy of S-1 for gastric cancer patients with positive
peritoneal lavage cytology. Hepatogastroenterology. 55:1939–1942.
2008.PubMed/NCBI
|
